Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.34 USD | +1.68% | +1.81% | +44.01% |
03-19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
03-15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.01% | 2.03B | |
-1.70% | 102B | |
+2.33% | 96.09B | |
+2.13% | 22.28B | |
-16.88% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-14.17% | 16.09B | |
+4.97% | 13.83B | |
+33.24% | 11.97B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Insider Sell: Keros Therapeutics